Evidence map›Paper›PMID 23899627›Full record

ArticleExperimental cell research2014

Green fluorescent protein expression triggers proteome changes in breast cancer cells.

J V F Coumans, D Gau, A Poljak, V Wasinger, P Roy, P Moens

Abstract read
In one paragraph

Article in Experimental cell research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Evaluating Cellular Viability by iTRAQ Proteomic Profiling.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

J V F CoumansSchool of Science and Technology, University of New England, Armidale, NSW, Australia; School of Rural Medicine, University of New England, Armidale, NSW, Australia. Electronic address: jmoensco@une.edu.au.
D Gau
A Poljak
V Wasinger
P Roy
P Moens
University of New England · AUUniversity of Pittsburgh · USUNSW Sydney · AU

Funding

Profilin as a target to suppress Invasive breast cancerR01CA108607 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROY, PARTHA · 2006 to 2017
$2.6M
NCI NIH HHS 2R01CA108607NCI NIH HHS R01 CA108607
6 · The paper itself

Abstract

Green fluorescent protein (GFP) is the most commonly used reporter of expression in cell biology despite evidence that it affects the cell physiology. The molecular mechanism of GFP-associated modifications has been largely unexplored. In this paper we investigated the proteome modifications following stable expression of GFP in breast cancer cells (MDA-MB-231). A combination of three different proteome analysis methods (2-DE, iTRAQ, label-free) was used to maximise proteome coverage. We found that GFP expression induces changes in expression of proteins that are associated with protein folding, cytoskeletal organisation and cellular immune response. In view of these findings, the use of GFP as a cell reporter should be carefully monitored.

Indexed as

ArtifactsBreast NeoplasmsElectrophoresis, Gel, Two-DimensionalFemaleGreen Fluorescent ProteinsHumansProteomeTumor Cells, CulturedGreen Fluorescent ProteinsProteome2-DECellular immune responseCytoskeleton modificationsGFPGFP expressiongreen fluorescence proteinisobaric tags for relative and absolute quantitationiTRAQProteomic changetwo-dimensional electrophoresisUnfolded protein response

Identifiers

PMID23899627
PMCPMC3866891
OpenAlexW1965483110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.